Catalent's Catalent Pharma Solutions Inc. subsidiary received exclusive, worldwide rights to Pantec's Lyopan technology

Pantec Biosolutions AG

Liechtenstein / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Catalent Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced